Table of Content
- 1. Executive Summary
- 2. Industry Introduction Taxonomy Market Definition
- 3. Market Trends and Success Factors Macro-economic Factors Market Dynamics Recent Industry Developments
- 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034 Historical Analysis Future Projections
- 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 5.1. Drug Class
- 5.2. Route of Administration
- 5.3. Patient Demographics
- 5.4. Disease Severity
- 5.5. Distribution Channel
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Drug Class
- 6.1. Azole Antifungals
- 6.2. Polyenes
- 6.3. Echinocandins
- 6.4. Combination Therapy
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration
- 7.1. Oral
- 7.2. Intravenous
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Patient Demographics
- 8.1. Adults
- 8.2. Pediatric
- 8.3. Immunocompromised Patients
- 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Disease Severity
- 9.1. Acute Coccidioidomycosis
- 9.2. Chronic Coccidioidomycosis
- 9.3. Disseminated Coccidioidomycosis
- 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel
- 10.1. Hospital Pharmacies
- 10.2. Retail Pharmacies
- 10.3. Online Pharmacies
- 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Western Europe
- 11.4. Eastern Europe
- 11.5. East Asia
- 11.6. South Asia & Pacific
- 11.7. MEA
- 12. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, By Key Segments and Countries
- 13. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, By Key Segments and Countries
- 14. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, By Key Segments and Countries
- 15. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, By Key Segments and Countries
- 16. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, By Key Segments and Countries
- 17. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, By Key Segments and Countries
- 18. MEA Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, By Key Segments and Countries
- 19. Sales Forecast 2024 to 2034 By Drug Class, Route of Administration, Patient Demographics, Disease Severity, and Distribution Channel for 30 Countries
- 20. Competition Outlook Market Structure Analysis Company Share Analysis by Key Players Competition Dashboard
- 21. Company Profile
- 21.1. Pfizer Inc.
- 21.2. Glenmark Pharmaceutical Inc.
- 21.3. Cipla Inc.
- 21.4. Sun Pharmaceutical Industries Ltd.
- 21.5. Viatris Inc.
- 21.6. Novartis AG (Sandoz)
- 21.7. Gilead Sciences, Inc.
- 21.8. Merck & Co., Inc.
- 21.9. Dr. Reddy's Laboratories (UK) Ltd
- 21.10. Xellia Pharmaceuticals
- 21.11. FUJIFILM Toyama Chemical Co., Ltd.
- 21.12. Nippon Chemiphar Co., Ltd.
